Imatinib Mesylate: In the Treatment of Gastrointestinal Stromal Tumours

By Croom K.F.   Perry C.M.  

Drugs, Vol. 63, Iss. 5, 2003-01 ,pp. : 513-522

Adis International

Access to resources Recommend Favorite

Imatinib mesylate in the treatment of gastrointestinal stromal tumour

By Steinert Dejka M   McAuliffe John C   Trent Jonathan C  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 1, 2005-01 ,pp. : 105-113

Informa Healthcare

Access to resources Recommend Favorite

Treatment of gastrointestinal stromal tumours: imatinib, sunitinib – and then?

By Nilsson Bengt   Nilsson Ola   Ahlman Håkan  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 4, 2009-04 ,pp. : 457-468

Informa Healthcare

Access to resources Recommend Favorite

Phase I/II study of sunitinib malate in Japanese patients with gastrointestinal stromal tumor after failure of prior treatment with imatinib mesylate

By Shirao Kuniaki   Nishida Toshirou   Doi Toshihiko   Komatsu Yoshito   Muro Kei   Li Yinhua   Ueda Eiji   Ohtsu Atsushi  

Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. : 866-875

Springer Publishing Company

Access to resources Recommend Favorite

Imatinib mesilate for the treatment of gastrointestinal stromal tumour

By Cassier Philippe A   Dufresne Armelle   Arifi Samia   Sayadi Hiba El   Labidi Intidar   Ray-Coquard Isabelle   Tabone Séverine   Méeus Pierre   Ranchère Dominique   Sunyach Marie-Pierre   Decouvelaere Anne-Valérie   Alberti Laurent   Blay Jean-Yves  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 7, 2008-05 ,pp. : 1211-1222

Informa Healthcare

Access to resources Recommend Favorite